PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Korean Journal of Medical History10.13081/kjmh.2015.24.7492015243749-782The Korean Pharmaceutical Industry and the Expansion of the General Pharmaceuticals Market in the 1950-1960s*Kyu-Hwan SIHNhttp://medhist.or.kr/upload/pdf/kjmh-24-3-749.pdf, http://medhist.or.kr/journal/view.php?doi=10.13081/kjmh.2015.24.749, http://www.medhist.or.kr/upload/pdf/kjmh-24-3-749.pdf
Journal of the American Pharmaceutical Association (Scientific ed.)10.1002/jps.30303909201950399535-537Biological safety tests for the quality control of parenteral pharmaceuticalsNathan Rakietenhttps://api.elsevier.com/content/article/PII:S0095955315320084?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0095955315320084?httpAccept=text/plain
Journal of Market Access & Health Policy10.1080/20016689.2017.13815442017511381544Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industryKarolina Badora, Aleksandra Caban, Cécile Rémuzat, Claude Dussart, Mondher Toumihttps://tandfonline.com/doi/pdf/10.1080/20016689.2017.1381544, https://www.tandfonline.com/doi/pdf/10.1080/20016689.2017.1381544
Drugs and Narcotics in History10.1017/cbo9780511599675.0101995168-186Research and development in the UK pharmaceutical industry from the nineteenth century to the 1960sJudy Slinnhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/E463D1517CF99B07A20AE569E89721E7
Pharmaceutical Medicine10.1007/bf03256753200923277-84Market Exclusivity Strategies for PharmaceuticalsCynthia Luchettihttp://link.springer.com/content/pdf/10.1007/BF03256753.pdf, http://link.springer.com/article/10.1007/BF03256753/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF03256753
Journal of the American Pharmaceutical Association (Practical Pharmacy ed.)10.1016/s0095-9561(16)32096-51950113164-190Development of Chemicals for the Pharmaceutical IndustryW.H. Engelshttps://api.elsevier.com/content/article/PII:S0095956116320965?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0095956116320965?httpAccept=text/plain
Pharmaceuticals10.3390/ph150505612022155561Functionalized Nitroimidazole Scaffold Construction and Their Pharmaceutical Applications: A 1950–2021 Comprehensive OverviewRia Gupta, Sumit Sharma, Rohit Singh, Ram A. Vishwakarma, Serge Mignani, Parvinder Pal Singhhttps://www.mdpi.com/1424-8247/15/5/561/pdf
The New Political Economy of Pharmaceuticals10.1057/9781137315854_62013111-133The Pharmaceutical Industry in India after TRIPSSudip Chaudhurihttp://link.springer.com/content/pdf/10.1057/9781137315854_6
Pharmaceutical & Diagnostic Innovation10.1007/bf032596412005366-9Paying Close Attention to the ADHD Markethttp://link.springer.com/content/pdf/10.1007/BF03259641.pdf, http://link.springer.com/article/10.1007/BF03259641/fulltext.html, http://link.springer.com/content/pdf/10.1007/BF03259641
Ethics and the Pharmaceutical Industry10.1017/cbo9780511610769.0202005225-248The Application of Cost-Effectiveness and Cost–Benefit Analysis to PharmaceuticalsJoel W. Hayhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/82842F79811FEE035BD7D04A0E4C4D50